At-211 radiochemical services
Atley Solutions offers world-class radiopharmaceutical development services with a focus on At-211 radiochemistry. Leveraging decades of expertise, cutting-edge facilities, and unmatched access to At-211, we empower drug developers to create novel radiopharmaceutical candidates and achieve scalable manufacturing solutions.
Our radiochemistry services are built on the following pillars:
Unparalleled expertise
Our service offering is grounded in decades of experience in At-211 radiochemistry, led by our Chief Science Officer, Dr. Emma Aneheim, and her team of experts.
R&D facilities
Located in Gothenburg, Sweden, our R&D alpha laboratory is fully equipped for radiochemistry development and features the Atley C100—the world’s first commercial At-211 manufacturing system.
Reliable At-211 supply
Weekly deliveries of high-activity At-211 from the cyclotron facility at Rigshospitalet in Copenhagen, Denmark, ensure reliable and consistent support for radiopharmaceutical development projects.
Our Services
Atley Solutions provides a range of services tailored to accelerate the development of At-211 radiopharmaceuticals:
- Feasibility projects: Early-stage evaluations to assess the viability of radiopharmaceutical concepts.
- Manual radiochemistry development: Hands-on expertise to develop and optimize novel or existing radiolabeling processes.
- Stability studies: Comprehensive testing to inform radiolabeling development and support shelf-life assessments.
- Radiochemistry automation: Development of automated manufacturing methods using the Atley C100, including the design and supply of customized consumable kits. This enables seamless transfer of manufacturing methods from our Gothenburg-based Atley C100 to modules installed worldwide.
This comprehensive service offering enables our partners to streamline and accelerate radiopharmaceutical development, leveraging Atley Solutions’ unique combination of expertise, advanced infrastructure, and reliable At-211 supply.